OppenheimerFunds’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $306K | Buy |
23,752
+6,289
| +36% | +$81K | ﹤0.01% | 1541 |
|
2018
Q4 | $265K | Sell |
17,463
-360
| -2% | -$5.46K | ﹤0.01% | 1622 |
|
2018
Q3 | $356K | Buy |
17,823
+2,038
| +13% | +$40.7K | ﹤0.01% | 1580 |
|
2018
Q2 | $308K | Sell |
15,785
-2,982
| -16% | -$58.2K | ﹤0.01% | 1625 |
|
2018
Q1 | $378K | Sell |
18,767
-9,352
| -33% | -$188K | ﹤0.01% | 1508 |
|
2017
Q4 | $373K | Buy |
28,119
+7,797
| +38% | +$103K | ﹤0.01% | 1611 |
|
2017
Q3 | $375K | Sell |
20,322
-6,216
| -23% | -$115K | ﹤0.01% | 1637 |
|
2017
Q2 | $488K | Buy |
26,538
+8,963
| +51% | +$165K | ﹤0.01% | 1512 |
|
2017
Q1 | $396K | Buy |
17,575
+8,836
| +101% | +$199K | ﹤0.01% | 1600 |
|
2016
Q4 | $304K | Buy |
8,739
+75
| +0.9% | +$2.61K | ﹤0.01% | 1590 |
|
2016
Q3 | $212K | Sell |
8,664
-735
| -8% | -$18K | ﹤0.01% | 1635 |
|
2016
Q2 | $225K | Buy |
+9,399
| New | +$225K | ﹤0.01% | 1574 |
|